Stock 300558 BETTA PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Betta Pharmaceuticals Co., Ltd.

Equities

300558

CNE100002DD9

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
40.54 CNY +3.66% Intraday chart for Betta Pharmaceuticals Co., Ltd. +12.49% -21.36%
Apr. 19 Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jan. 04 C4 Therapeutics, Inc. announced that it has received $24.999997 million in funding from Betta Pharmaceuticals Co., Ltd. CI

Evolution of the average Target Price on Betta Pharmaceuticals Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

0f43a6ec4766e8bcb39f.0_hNd1ghX-nmq4iht6iscNuKjDbmjgQbGnBTSCpl9nw.kKwLJgJOC7OTw9rCmtHECprp2mmEozdEfRg0HEUroiSlmioeE0ps3t-a-w~70c2f264eff67f67bc2fe79eaf9525fa

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
40.54 CNY
Average target price
54.14 CNY
Spread / Average Target
+33.53%
High Price Target
65 CNY
Spread / Highest target
+60.34%
Low Price Target
43.27 CNY
Spread / Lowest Target
+6.73%

Consensus detail

Consensus revision (last 18 months)

Ratings for Betta Pharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 300558 Stock
  4. Consensus Betta Pharmaceuticals Co., Ltd.